These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6693170)

  • 1. Lipopolysaccharide interaction with rabbit erythrocyte membranes.
    Carr C; Morrison DC
    Infect Immun; 1984 Feb; 43(2):600-6. PubMed ID: 6693170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of polymyxin B-mediated lysis of lipopolysaccharide-treated erythrocytes.
    Carr C; Morrison DC
    Infect Immun; 1985 Jul; 49(1):84-9. PubMed ID: 2989182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-step mechanism for the interaction of Re lipopolysaccharide with erythrocyte membranes.
    Carr C; Morrison DC
    Rev Infect Dis; 1984; 6(4):497-500. PubMed ID: 6474010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyxin B suppresses the endotoxin inhibition of concanavalin a-mediated erythrocyte agglutination.
    Warren JR
    Infect Immun; 1982 Feb; 35(2):594-9. PubMed ID: 6276306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane receptors of human erythrocytes for bacterial lipopolysaccharide (LPS).
    Yokoyama K; Terao T; Osawa T
    Jpn J Exp Med; 1978 Dec; 48(6):511-7. PubMed ID: 374801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of lipopolysaccharide-initiated rabbit platelet responses. II. Evidence that lipid A is responsible for binding of lipopolysaccharide to the platelet.
    Morrison DC; Oades ZG
    J Immunol; 1979 Mar; 122(3):753-8. PubMed ID: 448073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts.
    Freer E; Moreno E; Moriyón I; Pizarro-Cerdá J; Weintraub A; Gorvel JP
    J Bacteriol; 1996 Oct; 178(20):5867-76. PubMed ID: 8830680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Re lipopolysaccharide-binding protein on murine erythrocyte membrane.
    Kirikae T; Inada K; Hirata M; Yoshida M; Kondo S; Hisatsune K
    Microbiol Immunol; 1988; 32(1):33-44. PubMed ID: 2453783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of lipopolysaccharide interaction with human peripheral-blood monocytes.
    Warner SJ; Savage N; Mitchell D
    Biochem J; 1985 Dec; 232(2):379-83. PubMed ID: 3911946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased binding of antibiotics to lipopolysaccharides from polymyxin-resistant strains of Escherichia coli and Salmonella typhimurium.
    Peterson AA; Fesik SW; McGroarty EJ
    Antimicrob Agents Chemother; 1987 Feb; 31(2):230-7. PubMed ID: 3032093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway.
    Hidvégi T; Füst G; Rajnavölgyi E; Kulics J; Gergely J
    Immunology; 1985 Dec; 56(4):735-41. PubMed ID: 3935572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural features of binding of lipopolysaccharides to murine lymphocytes.
    Jacobs DM
    Rev Infect Dis; 1984; 6(4):501-5. PubMed ID: 6206543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of the lipopolysaccharide deacylase PagL from latency compensates for a lack of lipopolysaccharide aminoarabinose modification-dependent resistance to the antimicrobial peptide polymyxin B in Salmonella enterica.
    Kawasaki K; China K; Nishijima M
    J Bacteriol; 2007 Jul; 189(13):4911-9. PubMed ID: 17483225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semi-synthesis of polymyxin-B conjugated ovalbumin: evaluation of lipopolysaccharide binding avidity and neutralization of induced tnf-alpha synthesis.
    Coyne CP; Moritz JT; Langston VC
    Biotherapy; 1994; 8(1):69-83. PubMed ID: 7547083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B.
    Morrison DC; Jacobs DM
    Infect Immun; 1976 Jan; 13(1):298-301. PubMed ID: 175019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. II. Complement activating property of the lipopolysaccharide portion and the inhibition by polymyxin B.
    Inada K
    Jpn J Exp Med; 1980 Apr; 50(2):107-15. PubMed ID: 6256561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Perturbation of Pulmonary Surfactant by Bacterial Lipopolysaccharide and Its Reversal by Polymyxin B: Function and Structure.
    Kolomaznik M; Liskayova G; Kanjakova N; Hubcik L; Uhrikova D; Calkovska A
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29976869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of rough lipopolysaccharides (LPS) to human leukocytes. Inhibition by anti-LPS monoclonal antibody.
    Weersink AJ; Van Kessel KP; Torensma R; Van Strijp JA; Verhoef J
    J Immunol; 1990 Jul; 145(1):318-24. PubMed ID: 2162891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of lipopolysaccharide-induced TNF-alpha production by semisynthetic polymyxin-B conjugated dextran.
    Coyne CP; Moritz JT; Fenwick BW
    Biotechnol Ther; 1994-1995; 5(3-4):137-62. PubMed ID: 8608324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teicoplanin reduces in-vitro reactivity and murine lethality of Salmonella minnesota R595 lipopolysaccharide.
    Focà A; Matera G; Berlinghieri MC; Liberto MC; De Sarro GB
    J Antimicrob Chemother; 1992 Apr; 29(4):443-6. PubMed ID: 1535068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.